ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Nektar Therapeutics (NKTR)

Technical Analysis Report for NASDAQ stock NKTR Nektar Therapeutics. Dated: 05 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NKTR Nektar Therapeutics then click here. or read Experts views on Nektar Therapeutics or Forecast & share price targets of Nektar Therapeutics

Nektar Therapeutics Opened at 73.56 and Closed at: 73.09, which is 0.45% of previous session's close. It moved within a range of 72.00 and 74.23
The session was a Bearish session with an average volume of 581000, which is -23.56% of previous session's volumes.

  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 4 days back on short term averages

Support for tomorrow is 71.43 and resistance for tomorrow is 73.66
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 71.98, 70.88 resistance for tomorrow's hourly charts is 74.21, 75.34

10 Day SMA for Nektar Therapeutics (NKTR) is 71.28 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Nektar Therapeutics (NKTR) is 69.72 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Nektar Therapeutics (NKTR) is 66.12 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 72.35 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Nektar Therapeutics is 63.46 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Nektar Therapeutics is at 69.72 and 200 DMA is at 63.46, while 50 DMA and 100 DMA are at 66.12 and 72.35 respectively

Nektar Therapeutics (NKTR) moving average of 20 SMA is at 69.72 and 20 EMA is at 70.17

Nektar Therapeutics (NKTR) moving average of 50 SMA is at 66.12 and 50 EMA is at 69.23

Nektar Therapeutics (NKTR) moving average of 100 SMA is at 72.35 and 100 EMA is at 68.02

Nektar Therapeutics (NKTR) moving average of 200 SMA is at 63.46 and 200 EMA is at 60.11

Nektar Therapeutics has performed better than Xenon Pharmaceuticals in short term. Holding Nektar Therapeutics could be a better choice for now!

Tandem Diabetes has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Tandem Diabetes, about 23.28% more returns!

Nektar Therapeutics has performed better than Tg Therapeutics in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Bio Techne in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Repros Therapeutics in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Novavax Inc in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Nature S in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Mannkind Corporation in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Lemaitre Vascular in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Incyte Corporation in short term. Holding Nektar Therapeutics could be a better choice for now!

Geron Corporation has performed better than Nektar Therapeutics in short term. You could have earned much better returns by investing in Geron Corporation, about 4.15% more returns!

Nektar Therapeutics has performed better than Exelixis Inc in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Equillium Inc in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Cytokinetics Incorporated in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Celcuity Inc in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics has performed better than Arbutus Biopharma in short term. Holding Nektar Therapeutics could be a better choice for now!

Nektar Therapeutics Technical analysis of indicators

Price action analysis of Nektar Therapeutics (NKTR) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Nektar Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Nektar Therapeutics in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Nektar Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Nektar Therapeutics in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Nektar Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 71.23 and Nektar Therapeutics NKTR stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Nektar Therapeutics NKTR stock. Volume based technical analysis of Nektar Therapeutics NKTR stock is negative.

Nektar Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock NKTR Nektar Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And NKTR Experts View which covers a lot of information including buying and selling signals

NKTR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Nektar Therapeutics or View Candle Stick Charts here

Chart Nektar Therapeutics (NKTR)  Technical (Analysis) Reports Nektar Therapeutics [

Videos related to: Nektar Therapeutics (NKTR) Technical (Analysis) Reports Nektar Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Nektar Therapeutics (NKTR)  Technical (Analysis) Reports Nektar Therapeutics [

 

Back to top